Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A cross-over study between hydrallazine and prazosin

K Rasmussen, H A Jensen

    Clinical Science and Molecular Medicine. Supplement
    |December 1, 1976
    PubMed
    Summary

    Prazosin (an antihypertensive drug) is as effective as hydralazine, but may cause side effects. Further research is needed to confirm its role in hypertension management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Reliability-based optimization of maintenance scheduling of mechanical components under fatigue.

    Computer methods in applied mechanics and engineering·2013
    Same author

    Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer.

    British journal of cancer·2009
    Same author

    UFT (tegafur-uracil) in rectal cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2008
    Same author

    No evidence of gemcitabine accumulation during weekly administration.

    European journal of clinical pharmacology·2005
    Same author

    Resectability of rectal cancers still fixed after radio-chemotherapy: evaluation by digital rectal examination, MRI, and intraoperative examination.

    International journal of colorectal disease·2005
    Same author

    A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.

    Clinical nephrology·2001

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Hypertension is a prevalent cardiovascular condition requiring effective pharmacological management.
    • Hydralazine has been a traditional antihypertensive agent.
    • The efficacy and tolerability of prazosin as an alternative require investigation.

    Purpose of the Study:

    • To compare the antihypertensive efficacy of prazosin and hydralazine in patients treated with propranolol.
    • To assess the side effect profile of prazosin compared to hydralazine.

    Main Methods:

    • A cross-over study design was employed.
    • Fifteen hypertensive patients receiving propranolol participated.
    • Equipotency of 1 mg prazosin and 30 mg hydralazine was evaluated.

    Main Results:

    • One milligram of prazosin demonstrated equipotency to 30 mg of hydralazine.
    • Prazosin was generally tolerated, with one patient discontinuing due to severe headache.
    • Minor, transient side effects were observed in four patients, potentially avoidable with dose titration.

    Conclusions:

    • Prazosin presents a viable alternative to hydralazine for hypertension treatment.
    • The definitive role of prazosin as an antihypertensive medication remains to be established.
    • Careful dose titration may mitigate initial side effects of prazosin.

    Related Experiment Videos